Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-12-12 | New | $249,999,225 | $249,999,225 | Equity Only | 06b | SEC link |
| 2023-09-14 | New | $130,000,000 | $130,000,000 | Equity Only | 06b | SEC link |
| 2020-10-13 | New | $87,437,914 | $87,437,914 | Equity Only | 06b | SEC link |
| 2020-06-23 | Amended | $53,900,000 | $23,900,000 | Equity Only | 06b | SEC link |
| 2020-03-27 | New | $30,000,000 | $30,000,000 | Equity Only | 06b | SEC link |
| 2018-08-27 | New | $6,054,922 | $6,054,922 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Sean Bohen | Director, Executive |
| Sean Bohen, M.D., Ph.D. | Director, Executive |
| Marina Bozilenko | Director |
| Cynthia Butitta | Director |
| Ian Clark | Director |
| Lawrence Fritz | Director |
| Scott Garland | Director |
| Cyrus Harmon | Director, Executive |
| Cyrus L. Harmon, Ph.D. | Director |
| Kinney Horn | Executive |
| Sandra Horning, M.D. | Director |
| Gorjan Hrustanovic | Director |
| Gorjan Hrustanovic, Ph.D. | Director |
| Gorjan Hrustanovich | Director |
| Pamela Klein | Executive |
| Shane Kovacs | Executive |
| Peter Kusher | Director, Executive |
| Peter Kushner | Executive |
| Yi Larson | Director |
| Andrei Manoliu | Director |
| Frank Mc Cormick | Director |
| John Moriarty | Executive |
| David Myles | Executive |
| David C. Myles, Ph.D. | Executive |
| Andrew Rappaport | Director |
| Graham Walmsley | Director |
| Graham Walmsley, M.D., Ph.D. | Director |
| Naseem Zojwalla, M.D. | Executive |